| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/17/2023 | 175.86% | Piper Sandler | $12 → $8 | Maintains | Overweight |
| 09/20/2023 | 210.34% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 08/29/2023 | 210.34% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 08/29/2023 | 693.1% | Cantor Fitzgerald | → $23 | Reiterates | Overweight → Overweight |
| 08/18/2023 | 210.34% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/24/2023 | 210.34% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/18/2023 | 210.34% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/15/2023 | 210.34% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 04/24/2023 | 210.34% | HC Wainwright & Co. | → $9 | Initiates Coverage On | → Buy |
| 11/23/2022 | 313.79% | Piper Sandler | $19 → $12 | Maintains | Overweight |
| 04/14/2022 | 589.66% | Cantor Fitzgerald | → $20 | Initiates Coverage On | → Overweight |
| 04/08/2022 | 555.17% | Piper Sandler | → $19 | Initiates Coverage On | → Overweight |
| 04/04/2022 | 624.14% | Citigroup | → $21 | Initiates Coverage On | → Buy |
What is the target price for Alpha Tau Medical (DRTS)?
The latest price target for Alpha Tau Medical (NASDAQ: DRTS) was reported by Piper Sandler on November 17, 2023. The analyst firm set a price target for $8.00 expecting DRTS to rise to within 12 months (a possible 175.86% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Alpha Tau Medical (DRTS)?
The latest analyst rating for Alpha Tau Medical (NASDAQ: DRTS) was provided by Piper Sandler, and Alpha Tau Medical maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Alpha Tau Medical (DRTS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alpha Tau Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alpha Tau Medical was filed on November 17, 2023 so you should expect the next rating to be made available sometime around November 17, 2024.
Is the Analyst Rating Alpha Tau Medical (DRTS) correct?
While ratings are subjective and will change, the latest Alpha Tau Medical (DRTS) rating was a maintained with a price target of $12.00 to $8.00. The current price Alpha Tau Medical (DRTS) is trading at is $2.90, which is out of the analyst's predicted range.